Your browser doesn't support javascript.
loading
Birth length is the strongest predictor of linear growth status and stunting in the first 2 years of life after a preconception maternal nutrition intervention: the children of the Women First trial.
Krebs, Nancy F; Hambidge, K Michael; Westcott, Jamie L; Garcés, Ana L; Figueroa, Lester; Tshefu, Antoinette K; Lokangaka, Adrien L; Goudar, Shivaprasad S; Dhaded, Sangappa M; Saleem, Sarah; Ali, Sumera Aziz; Bauserman, Melissa S; Derman, Richard J; Goldenberg, Robert L; Das, Abhik; Chowdhury, Dhuly.
Afiliação
  • Krebs NF; Department of Pediatrics, Section of Nutrition, University of Colorado School of Medicine, Denver, CO, USA.
  • Hambidge KM; Department of Pediatrics, Section of Nutrition, University of Colorado School of Medicine, Denver, CO, USA.
  • Westcott JL; Department of Pediatrics, Section of Nutrition, University of Colorado School of Medicine, Denver, CO, USA.
  • Garcés AL; Unidad de Salud Materno Infantil, Instituto de Nutrición de Centroamérica y Panamá (INCAP), Calzada Roosevelt, Guatemala City, Guatemala.
  • Figueroa L; Unidad de Salud Materno Infantil, Instituto de Nutrición de Centroamérica y Panamá (INCAP), Calzada Roosevelt, Guatemala City, Guatemala.
  • Tshefu AK; Kinshasa School of Public Health, Hôpital Général de Kinshasa, Kinshasa, Democratic Republic of the Congo.
  • Lokangaka AL; Kinshasa School of Public Health, Hôpital Général de Kinshasa, Kinshasa, Democratic Republic of the Congo.
  • Goudar SS; KLE Academy of Higher Education and Research, Jawaharlal Nehru Medical College, Belagavi, India.
  • Dhaded SM; KLE Academy of Higher Education and Research, Jawaharlal Nehru Medical College, Belagavi, India.
  • Saleem S; Department of Community Health Sciences, Aga Khan University, Karachi, Pakistan.
  • Ali SA; Department of Community Health Sciences, Aga Khan University, Karachi, Pakistan.
  • Bauserman MS; Department of Pediatrics Neonatal-Perinatal Medicine, University of North Carolina, Chapel Hill, NC, USA.
  • Derman RJ; Department of OBGYN, Thomas Jefferson University, Philadelphia, PA, USA.
  • Goldenberg RL; Department of OBGYN, Columbia University Medical Center, New York, NY, USA.
  • Das A; RTI International, Durham, NC, USA.
  • Chowdhury D; RTI International, Durham, NC, USA.
Am J Clin Nutr ; 116(1): 86-96, 2022 07 06.
Article em En | MEDLINE | ID: mdl-35681255
BACKGROUND: The multicountry Women First trial demonstrated that nutritional supplementation initiated prior to conception (arm 1) or early pregnancy (arm 2) and continued until delivery resulted in significantly greater length at birth and 6 mo compared with infants in the control arm (arm 3). OBJECTIVES: We evaluated intervention effects on infants' longitudinal growth trajectory from birth through 24 mo and identified predictors of length status and stunting at 24 mo. METHODS: Infants' anthropometry was obtained at 6, 12, 18, and 24 mo after the Women First trial (registered at clinicaltrials.gov as NCT01883193), which was conducted in low-resource settings: Democratic Republic of Congo, Guatemala, India, and Pakistan. Longitudinal models evaluated intervention effects on infants' growth trajectory from birth to 24 mo, with additional modeling used to identify adjusted predictors for growth trajectories and outcomes at 24 mo. RESULTS: Data for 2337 (95% of original live births) infants were evaluated. At 24 mo, stunting rates were 62.8%, 64.8%, and 66.3% for arms 1, 2, and 3, respectively (NS). For the length-for-age z-score (LAZ) trajectory, treatment arm was a significant predictor, with adjusted mean differences of 0.19 SD (95% CI: 0.08, 0.30; P < 0.001) and 0.17 SD (95% CI: 0.07, 0.27; P < 0.001) for arms 1 and 2, respectively. The strongest predictors of LAZ at 24 mo were birth LAZ <-2 and <-1 to ≥-2, with adjusted mean differences of -0.76 SD (95% CI: -0.93, -0.58; P < 0.001) and -0.47 SD (95% CI: -0.56, -0.38; P < 0.001), respectively. For infants with ultrasound-determined gestational age (n = 1329), the strongest predictors of stunting were birth LAZ <-2 and <-1 to ≥- 2: adjusted relative risk of 1.62 (95% CI: 1.39, 1.88; P < 0.001) and 1.46 (95% CI: 1.31, 1.62; P < 0.001), respectively. CONCLUSIONS: Substantial improvements in postnatal growth are likely to depend on improved intrauterine growth, especially during early pregnancy.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenômenos Fisiológicos da Nutrição Materna / Transtornos do Crescimento Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Female / Humans / Infant / Newborn / Pregnancy Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenômenos Fisiológicos da Nutrição Materna / Transtornos do Crescimento Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Female / Humans / Infant / Newborn / Pregnancy Idioma: En Ano de publicação: 2022 Tipo de documento: Article